--- title: "SBIR/STTR, SBIR / STTR Grants | MedTech Terms" description: "U.S. federal small-business R&D grants from agencies including NIH and DoD. Plain-English Investment & Finance definition for MedTech teams, with examples and r" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/sbir-sttr#term", "name": "SBIR / STTR Grants", "alternateName": "SBIR/STTR", "description": "Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) are U.S. federal grant programs that fund early-stage R&D at small businesses. NIH, NSF, DoD, and BARDA are the most relevant agencies for MedTech. Phase I (~$300K) funds feasibility; Phase II (~$2M) funds prototype and validation.", "url": "https://medtechterms.com/terms/sbir-sttr", "termCode": "sbir-sttr", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/sbir-sttr#article", "headline": "SBIR/STTR, SBIR / STTR Grants", "description": "U.S. federal small-business R&D grants from agencies including NIH and DoD.", "url": "https://medtechterms.com/terms/sbir-sttr", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/sbir-sttr" }, "about": { "@id": "https://medtechterms.com/terms/sbir-sttr#term" }, "articleSection": "Investment & Finance", "inLanguage": "en", "keywords": "SBIR / STTR Grants, SBIR/STTR, Investment & Finance, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "SBIR.gov", "url": "https://www.sbir.gov/", "publisher": { "@type": "Organization", "name": "SBIR.gov" } }, { "@type": "CreativeWork", "name": "NIH SEED", "url": "https://seed.nih.gov/", "publisher": { "@type": "Organization", "name": "NIH" } }, { "@type": "CreativeWork", "name": "NVCA Model Documents", "url": "https://nvca.org/model-legal-documents/", "publisher": { "@type": "Organization", "name": "NVCA" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/non-dilutive-funding#term", "name": "Non-Dilutive Funding", "url": "https://medtechterms.com/terms/non-dilutive-funding" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Investment & Finance", "item": "https://medtechterms.com/terms?cat=Investment%20%26%20Finance" }, { "@type": "ListItem", "position": 4, "name": "SBIR / STTR Grants", "item": "https://medtechterms.com/terms/sbir-sttr" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/sbir-sttr#faq", "mainEntity": [ { "@type": "Question", "name": "Do SBIR/STTR grants require specific regulatory compliance documentation during the grant application or reporting phases?", "acceptedAnswer": { "@type": "Answer", "text": "While the grant application itself doesn't typically demand full regulatory compliance documentation, strong proposals often include a well-considered regulatory strategy, especially for Phase II, demonstrating an understanding of the path to market." } }, { "@type": "Question", "name": "How do SBIR/STTR grants impact a medical device company's quality management system (QMS)?", "acceptedAnswer": { "@type": "Answer", "text": "Even during early-stage, grant-funded R&D, it is prudent for MedTech companies to begin establishing elements of a QMS, congruent with principles outlined in ISO 13485, to ensure that design controls and documentation are managed effectively as device development progresses." } }, { "@type": "Question", "name": "Can SBIR/STTR funds be used for regulatory submissions or pre-market activities?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, funds from Phase II SBIR/STTR grants can often be allocated towards activities directly supporting regulatory submissions, such as conducting verification and validation testing, engaging regulatory consultants, or preparing documentation required by regulatory bodies like the FDA." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Investment & Finance](/terms?cat=Investment%20%26%20Finance) 6. / 7. SBIR / STTR Grants [All terms](/terms) Investment & Finance [Startup Lifecycle](/ecosystems/startup-lifecycle)SBIR/STTR # SBIR / STTR Grants U.S. federal small-business R&D grants from agencies including NIH and DoD. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) are U.S. federal grant programs that fund early-stage R&D at small businesses. NIH, NSF, DoD, and BARDA are the most relevant agencies for MedTech. Phase I (~$300K) funds feasibility; Phase II (~$2M) funds prototype and validation. What the regulation says SBIR/STTR grants, while providing [non-dilutive funding](/terms/non-dilutive-funding) for MedTech innovation, fall outside the direct purview of typical regulatory frameworks like 21 CFR Part 820 for [Quality System Regulation](/terms/qsr) or [ISO 13485](/terms/iso-13485) for Medical Devices, since they primarily concern funding mechanisms rather than product quality or safety. However, the R&D activities funded by these grants are still subject to relevant regulations and standards based on the nature of the medical device being developed, such as FDA design control requirements found in 21 CFR 820.30 during Phase II. Similarly, if clinical studies are involved, then [Good Clinical Practice](/terms/gcp) (GCP) guidelines, like those outlined by the ICH E6(R2) guideline, must be followed. ## What this means in practice Non-dilutive, retains IP with the small business, and signals scientific credibility. Highly competitive; success rates around 15–20% for NIH. ## Examples - A small business uses a Phase I SBIR grant to conduct feasibility studies for a novel diagnostic device, including preliminary assessments of user needs and potential hazards as part of an early risk management process. - A MedTech startup utilizes Phase II STTR funding to develop a prototype surgical tool and performs verification testing following a design plan, adhering to initial design control principles. - A company developing an AI-powered medical imaging tool uses SBIR funds to conduct performance studies, ensuring data integrity and algorithm validation in preparation for a future FDA premarket submission. Common pitfalls - • A common pitfall is misunderstanding that securing an SBIR/STTR grant automatically confers regulatory approval or streamlines the regulatory submission process. - • Another mistake is neglecting to integrate regulatory strategy and quality system considerations early in the R&D process, even during the grant-funded phases. - • Companies often fail to allocate sufficient grant funds and resources specifically for crucial regulatory activities, such as biocompatibility testing or electromagnetic compatibility (EMC) testing, which are necessary for eventual market authorization. - • Assuming that the technical success criteria for a grant are the same as the regulatory requirements for market clearance or approval can lead to significant delays. - • Mismanaging intellectual property generated during the grant project can create future regulatory and commercial challenges, despite the grants’ general policy of retaining IP with the small business. ## Frequently asked questions Do SBIR/STTR grants require specific regulatory compliance documentation during the grant application or reporting phases? While the grant application itself doesn't typically demand full regulatory compliance documentation, strong proposals often include a well-considered regulatory strategy, especially for Phase II, demonstrating an understanding of the path to market. How do SBIR/STTR grants impact a medical device company's quality management system (QMS)? Can SBIR/STTR funds be used for regulatory submissions or pre-market activities? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Investment & Finance Non-Dilutive Funding Capital that does not require giving up equity, such as grants or debt. ](/terms/non-dilutive-funding) ### More in Investment & Finance · Same category [ Investment & Finance 409A Valuation An independent fair-market-value appraisal of common stock used to set tax-compliant strike prices for employee stock options. ](/terms/409a-valuation)[ Investment & Finance Anti-Dilution Protection Adjustment that protects investors if the company raises a future round at a lower price. ](/terms/anti-dilution)[ Investment & Finance Bridge Round Interim financing between priced rounds, usually convertible. ](/terms/bridge-round)[ Investment & Finance Burn Rate Rate at which a company spends cash, typically expressed monthly. ](/terms/burn-rate) Cited by Where this term appears across MedTech Terms. Ecosystems (1) - [Startup Lifecycle](/ecosystems/startup-lifecycle) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 SBIR.gov· 1 NIH· 1 NVCA· 1 1. [1 SBIR.gov Verified SBIR.gov · sbir.gov ](https://www.sbir.gov/) 2. [2 NIH SEED Verified NIH · seed.nih.gov ](https://seed.nih.gov/) 3. [3 NVCA Model Documents Verified NVCA · nvca.org ](https://nvca.org/model-legal-documents/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Diligencing a MedTech cybersecurity posture? Blue Goat Cyber supports investors and acquirers with cybersecurity diligence on connected MedTech assets. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Investment & Finance Acronym SBIR/STTR Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=sbir-sttr) Learn in 60 seconds Card Lesson Quiz U.S. federal small-business R&D grants from agencies including NIH and DoD. - · Non-dilutive, retains IP with the small business, and signals scientific credibility. - · Highly competitive; success rates around 15–20% for NIH. - · federal grant programs that fund early-stage R&D at small businesses. Remember this Watch out: A common pitfall is misunderstanding that securing an SBIR/STTR grant automatically confers regulatory approval or streamlines the regulatory submission process. Related terms - [Non-Dilutive Funding ](/terms/non-dilutive-funding) You may also need Auto-suggested from Investment & Finance and shared keywords. - [Series A / B / C Financing Rounds ](/terms/series-funding) - [Fogarty Innovation ](/terms/fogarty-innovation) - [Earn-Out ](/terms/earn-out) - [Limited Partner / General Partner(LP / GP) ](/terms/lp-gp) - [Liquidity Event ](/terms/liquidity-event) - [Royalty Financing ](/terms/royalty-financing) [All Investment & Finance terms](/terms?cat=Investment%20%26%20Finance) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)